Indivior PLC
OTC: IZQVF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mark Crossley
- Employees
- 1,000
- Headquarters
- North Chesterfield, United States
- IPO year
- 2014
- Market cap
- $2.9B
- Website
- https://www.indivior.com
Loading IZQVF…
Loading profile data…Frequently asked questions about IZQVF
What does Indivior PLC (IZQVF) do?
Indivior PLC, along with its various associated companies, focuses on the creation, production, and distribution of buprenorphine-derived prescription pharmaceuticals. These medications are primarily utilized in the management of opioid addiction and concurrent mental health disorders. The firm's ongoing product development initiatives are geare...
Where does IZQVF trade?
Indivior PLC (IZQVF) trades on the Other OTC.
What sector is IZQVF in?
Indivior PLC (IZQVF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Indivior PLC?
Mark Crossley is the chief executive officer of Indivior PLC (IZQVF).
Where is Indivior PLC headquartered?
Indivior PLC is headquartered in United States.
Does IZQVF pay a dividend?
Indivior PLC (IZQVF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IZQVF go public?
Indivior PLC (IZQVF) completed its initial public offering in 2014.